Derek Y. Cruz-Arroyo, born 11/20/2007, male, had a test for Mycoplasma pneumoniae IgM antibodies which was reactive, indicating the presence of IgM antibodies to Mycoplasma pneumoniae. Mycoplasma pneumoniae is a bacteria that causes atypical pneumonia with flu-like symptoms. The test results should be used along with the patient's clinical evaluation and other diagnostic procedures. IgM antibodies to Mycoplasma pneumoniae usually indicate a recent primary infection but can sometimes persist for extended periods.
Derek Y. Cruz-Arroyo, born 11/20/2007, male, had a test for Mycoplasma pneumoniae IgM antibodies which was reactive, indicating the presence of IgM antibodies to Mycoplasma pneumoniae. Mycoplasma pneumoniae is a bacteria that causes atypical pneumonia with flu-like symptoms. The test results should be used along with the patient's clinical evaluation and other diagnostic procedures. IgM antibodies to Mycoplasma pneumoniae usually indicate a recent primary infection but can sometimes persist for extended periods.
Derek Y. Cruz-Arroyo, born 11/20/2007, male, had a test for Mycoplasma pneumoniae IgM antibodies which was reactive, indicating the presence of IgM antibodies to Mycoplasma pneumoniae. Mycoplasma pneumoniae is a bacteria that causes atypical pneumonia with flu-like symptoms. The test results should be used along with the patient's clinical evaluation and other diagnostic procedures. IgM antibodies to Mycoplasma pneumoniae usually indicate a recent primary infection but can sometimes persist for extended periods.
Derek Y. Cruz-Arroyo, born 11/20/2007, male, had a test for Mycoplasma pneumoniae IgM antibodies which was reactive, indicating the presence of IgM antibodies to Mycoplasma pneumoniae. Mycoplasma pneumoniae is a bacteria that causes atypical pneumonia with flu-like symptoms. The test results should be used along with the patient's clinical evaluation and other diagnostic procedures. IgM antibodies to Mycoplasma pneumoniae usually indicate a recent primary infection but can sometimes persist for extended periods.
Laboratorio Clínico Borinquen - Dorado Centro Comercial Plaza Dorada Col. Tec. Med. P.R. 0486761-00 11/20/2007 M 1 Pat. No.: 0000109 AveJoseEfron PR693 BoHiguillan DORADO, PR 00646-9998 Paid 5 Cents Physician Name Exp: 3/31/2024 DIRECTOR: Dr Jose Simons Num: 000942854 MIRANDA-GONZALEZ, LOIDA LIC #1207 CLIA # 40D1107161 TEL: (787) 665-7018 FAX: (787) 278-0366 Origin / Special Instructions
ª*ŸÞ<VZ¬ 012903110 L551 PLAZA DORADA / ENVIO A MISRESU
Request Reference Ordered On Supervisor
CRUZ-ARROYO, DEREK Y. 5/04/2023 7:34PM WRR URB CIARA DEL SOL 2 CALLE CIARA DEL SOL C017:486761-001 Reported On M.T. VEGA BAJA, PR 00693 *00000847* 5/04/2023 8:20PM JCNG
Test Units Results Graphic Normal Range
MYCOPLASMA PNEUMONIAE IgM
Mycoplasma pneumoniae IgM...............REACTIVE Method: A Rapid Enzyme Immunoassay (EIA) Reference Range: Reactive Test Result: A reactive result indicates the presence of IgM to M.pneumoniae. Nonreactive Test Result: Nonreactive results indicate either the absence of IgM to M.pneumoniae. Mycoplasma pneumoniae is a member of a group of degenerate bacteria lacking a cell wall. M.pneumoniae was the first human pathogen identified in the group and causes up to 20% of all cases of pneumonia. Mycoplasmal pneumonia presents with flu-like symptoms, however unlike most viral and bacterial pneumonias, mycoplasmal pneumonia is more gradual in both presentation and recovery. M.pneumoniae infections are usually grouped in the category of atypical pneumonia. Test results should be used in conjuction with information available from the patient clinical evaluation and other available diagnostic procedures. Specific IgM AB to M.pneumoniae are usually detected in patients with a recent primary infection. They may be found in patients with reactived or secondary infections and are sometimes found in patients with no other detectable evidence of recent infection. In addition, IgM to M.pneumoniae has been shown to persist for extended periods(2-12 months)in some patients. Results from immuno-suppressed individuals should be interpreted with caution. Limitations: Positive test results may not be valid in persons who have received blood transfusions or other products within the past several months. Physicians need to avoid patient treatment based solely on any single test result, and should interpret all results in context of other clinical and laboratory features. TEST VALIDATED BY: L:9331-JCNG 5/04/2023 8:20PM